Patents by Inventor Anna Maria Hedlund

Anna Maria Hedlund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8828652
    Abstract: The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: September 9, 2014
    Assignee: The Regents of the University of California
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen
  • Publication number: 20140044798
    Abstract: The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans.
    Type: Application
    Filed: August 13, 2013
    Publication date: February 13, 2014
    Applicant: The Regents of The University of California
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen
  • Patent number: 8541231
    Abstract: The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: September 24, 2013
    Assignee: The Regents of the University of California
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen
  • Publication number: 20130039991
    Abstract: The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans.
    Type: Application
    Filed: June 20, 2012
    Publication date: February 14, 2013
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen
  • Patent number: 8232448
    Abstract: This application is in the field of sialic acid chemistry, metabolism, antigenicity, and the production of transgenic non-human mammals with altered sialic acid production. More particularly, this application relates to N-glycolylneuraminic acid (Neu5Gc) being an immunogen in humans, and the production of Neu5Gc-free mammalian products for laboratory and human use.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: July 31, 2012
    Assignee: The Regents of the University of California
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen
  • Publication number: 20100293624
    Abstract: This application is in the field of sialic acid chemistry, metabolism, antigenicity, and the production of transgenic non-human mammals with altered sialic acid production. More particularly, this application relates to N-glycolylneuraminic acid (Neu5Gc) being an immunogen in humans, and the production of Neu5Gc-free mammalian products for laboratory and human use.
    Type: Application
    Filed: June 8, 2006
    Publication date: November 18, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen
  • Publication number: 20080166805
    Abstract: This application is in the field of sialic acid chemistry, metabolism, antigenicity, and the production of transgenic non-human mammals with altered sialic acid production. More particularly, this application relates to N-glycolylneuraminic acid (Neu5Gc) being an immunogen in humans, and the production of Neu5Gc-free mammalian products for laboratory and human use.
    Type: Application
    Filed: June 8, 2006
    Publication date: July 10, 2008
    Applicant: The Regents of the University of California
    Inventors: Ajit Varki, Anna Maria Hedlund, Dzung Nguyen